EUVIMEDEUVIMED entdecken
Fallbericht

Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment

Yin Ye, Zonghan Zhao, Wenjian Mo, Wei Liu, Liangliang Wu, Jianchao Li, Wenqing Zhang, Zhibin Huang, Shunqing Wang

Annals of Hematology · 2025

DOI: 10.1007/s00277-024-06169-x ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, 2025. Verfasst von Yin Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, Disease Models, Animal. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project, Guangzhou General Science and Technology Project of Health and Family Planning, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute promyelocytic leukemia (APL) is driven by the specific fusion gene PML-RARA produced by chromosomal translocation. Three classic isoforms, L, V, and S, are found in more than 95% of APL patients. However, atypical PML-RARA isoforms are usually associated with uncertain disease progression and treatment prognosis. Recently, we found a novel PML-RARA isoform (named PA) in a patient with atypical clinical characteristics of APL. In order to provide valuable insights for clinical treatment, we constructed the novel PML-RARA isoform zebrafish model for all-trans retinoic acid (ATRA) treatment experiments and comparison with classical isoforms. We found that the effect of PA PML-RARA on the expression of neutrophil-related genes was comparable with classical isoforms and ATRA treatment worked successfully in the zebrafish model. Sequence and structure analysis of the PA protein confirmed its similarity to classical isoforms and the fusion site of PA PML-RARA did not affect the ATRA binding site. As expected, the patient achieved complete remission within two months of treatment with ATRA in combination with arsenic trioxide (ATO) and had a favorable prognosis during the three-year follow-up. Our study highlights the accuracy and efficacy of the PML-RARA zebrafish model in combination with protein structure prediction in support of clinical treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Promyelocytic, AcuteOncogene Proteins, FusionDisease Models, AnimalZebrafishAnimalsHumansProtein IsoformsTretinoinArsenic TrioxideAnimals, Genetically ModifiedZebrafish ProteinsMaleAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Acute promyelocytic leukemiaAll-trans retinoic acidPML-RARAZebrafish model

Substanzen

Oncogene Proteins, FusionProtein IsoformsTretinoinpromyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinArsenic TrioxideZebrafish Proteins

Autor:innen und Institutionen

  • Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China.
  • Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou, 510006, China.
  • Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China. mczhangwq@scut.edu.cn.
  • Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou, 510006, China. mczhangwq@scut.edu.cn.
  • Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China. huangzhb1986@scut.edu.cn.
  • Division of Cell, Developmental and Integrative Biology, School of Medicine, South China University of Technology, Guangzhou, 510006, China. huangzhb1986@scut.edu.cn.

Förderung

  • Guangzhou Municipal Science and Technology Project
  • Guangzhou General Science and Technology Project of Health and Family Planning
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Ye, Y., Zhao, Z., Mo, W., Liu, W., Wu, L., Li, J., Zhang, W., Huang, Z., & Wang, S. (2025). Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment. Annals of Hematology. https://doi.org/10.1007/s00277-024-06169-x

Vancouver

Ye Y, Zhao Z, Mo W, Liu W, Wu L, Li J, et al. Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment. Annals of Hematology. 2025. doi:10.1007/s00277-024-06169-x

BibTeX
@article{Ye2025,
  author = {Ye, Yin and Zhao, Zonghan and Mo, Wenjian and Liu, Wei and Wu, Liangliang and Li, Jianchao and Zhang, Wenqing and Huang, Zhibin and Wang, Shunqing},
  title = {Zebrafish modeling of atypical PML-RARA isoform from acute promyelocytic leukemia patient and its implications for clinical treatment},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-024-06169-x}
}
Kostenlos starten →